Abstract
BackgroundThe increased availability of myositis-specific-auto-antibodies (MSA) and myositis-associated auto-antibodies (MAA) represent new possibilities and challenges in everyday clinical practice for the classification of possible inflammatory rheumatic diseases (IRD). In order...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
